Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of anidulafungin during continuous venovenous hemofiltration
2008-007753-12Phase 4Completed
- Sponsor
- Medical University of Vienna, Department of Infectious Diseases and Tropical Medicine
- Start
- Jan 2009
- Modality
- Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of anidulafungin in mycoses, sponsored by Medical University of Vienna, Department of Infectious Diseases and Tropical Medicine. Primary endpoint: Pharmacokinetic profile of anidulafungin during CVVHDF. Started Jan 2009; status: completed.
02
Drugs
anidulafungin
03
Conditions
mycoses
Beyond the preview
Go deeper on 2008-007753-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007753-12.